Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Prieto

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Plos One|September 10, 2013
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance systemPreciosa M Coloma, Martijn J Schuemie, Gianluca Trifirò, et al.
The British Journal of Dermatology|January 29, 2025
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohortElizaveta Gribaleva, Kaitlyn Chan, Carlos Chivardi, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Skin Health and Disease|June 30, 2025
A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocolElizaveta Gribaleva, Niels Steen Krogh, David Prieto-Merino, et al.
The British Journal of Dermatology|July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR registerHelen Alexander, Rayka Malek, David Prieto-Merino, et al.
Journal of the National Cancer Institute|April 27, 2012
Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposureMarcus R Munafò, Maria N Timofeeva, Richard W Morris, et al.
The Journal of Investigative Dermatology|September 5, 2025
Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries CollaborationNiels Steen Krogh, David Prieto-Merino, Bolaji Coker, et al.
Circulation|January 10, 2015
Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohortsPeter Würtz, Aki S Havulinna, Pasi Soininen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registryAnnelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Birth Defects Research|February 27, 2024
Gastroschisis prevalence patterns in 27 surveillance programs from 24 countries, International Clearinghouse for Birth Defects Surveillance and Research, 1980-2017Marcia L Feldkamp, Mark A Canfield, Sergey Krikov, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Plos One|September 10, 2013
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance systemPreciosa M Coloma, Martijn J Schuemie, Gianluca Trifirò, et al.
The British Journal of Dermatology|January 29, 2025
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohortElizaveta Gribaleva, Kaitlyn Chan, Carlos Chivardi, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Skin Health and Disease|June 30, 2025
A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocolElizaveta Gribaleva, Niels Steen Krogh, David Prieto-Merino, et al.
The British Journal of Dermatology|July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR registerHelen Alexander, Rayka Malek, David Prieto-Merino, et al.
Journal of the National Cancer Institute|April 27, 2012
Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposureMarcus R Munafò, Maria N Timofeeva, Richard W Morris, et al.
The Journal of Investigative Dermatology|September 5, 2025
Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries CollaborationNiels Steen Krogh, David Prieto-Merino, Bolaji Coker, et al.
Circulation|January 10, 2015
Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohortsPeter Würtz, Aki S Havulinna, Pasi Soininen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registryAnnelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Birth Defects Research|February 27, 2024
Gastroschisis prevalence patterns in 27 surveillance programs from 24 countries, International Clearinghouse for Birth Defects Surveillance and Research, 1980-2017Marcia L Feldkamp, Mark A Canfield, Sergey Krikov, et al.
Pageof 18